Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cluster analysis identifies anti-synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti-Synthetase Syndrome project database.

Created on 12 Nov 2026

Authors

Akira Yoshida, Iazsmin Bauer Ventura, Eduardo Dourado, Giovanni Zanframundo, Sara Faghihi-Kashani, Aravinthan Loganathan, Daphne Rivero Gallegos, Francisca Bozan, Gianluca Sambataro, Sangmee Sharon Bae, Laure Gallay, Albert Selva-O'Callaghan, Andrew L Mammen, Carlomaurizio Montecucco, Chester V Oddis, David F Fiorentino, Francesco Bonella, Frederick W Miller, Ingrid E Lundberg, Jorge Rojas-Serrano, Masataka Kuwana, Miguel Angel González-Gay, Neil McHugh, Tamera J Corte, Tracy Jennifer Doyle, Vega Jovani, Linda Carli, Pier Paolo Sainaghi, Natsuka Umezawa, Merrilee Needham, Giovanni Cagnotto, Nair Perez-Gómez, Paola Tomietto, Massimiliano Limonta, Maria Giovanna Danieli, Antonella Notarnicola, José Cifrian-Martinez, Julia Martinez-Barrio, Helena Andersson, Yasuhiro Kondoh, Reinhard Edmund Voll, Stylianos Tomaras, Pari Basharat, Farah Tamirou, Paola Parronchi, Matthias Schneider, CLASS project participating investigators, Lorenzo Cavagna, Rohit Aggarwal

Published in

Arthritis & rheumatology (Hoboken, N.J.). Nov 11, 2026. Epub Nov 11, 2026.

Abstract

To better characterize the clinical phenotypes and heterogeneity of anti-synthetase syndrome (ASyS), we performed unsupervised cluster analyses using clinical and serological data from the Classification Criteria for Anti-Synthetase Syndrome (CLASS) project database.
The CLASS database comprised 2,035 ASyS cases and 2,140 comparators with mimicking conditions, namely systemic autoimmune rheumatic diseases and/or interstitial lung disease (ILD), contributed by 103 centers worldwide. We applied multiple correspondence analysis followed by hierarchical clustering using 19 clinical and serological variables to classify ASyS and comparators in the entire CLASS cohort into distinct subgroups. We then repeated the cluster analysis in the ASyS cohort alone to identify phenotypic subgroups of ASyS.
Cluster analysis of the entire cohort identified three subgroups. Whereas Cluster 1 (n = 1,311) and Cluster 3 (n = 1,468) predominantly comprised ASyS and comparators, respectively, Cluster 2 (n = 1,105) included both groups. Interstitial pneumonia with autoimmune features (without anti-synthetase autoantibodies) and systemic sclerosis were more prevalent in Cluster 2, whereas dermatomyositis and polymyositis were predominantly represented in Cluster 3. Cluster analysis of the ASyS cohort identified three distinct subgroups: Cluster 1 (anti-Jo-1-positive, "full-spectrum" ASyS with myositis, ILD, and arthritis; n = 1,034), Cluster 2 (ILD-predominant; n = 581), and Cluster 3 (without ILD; n = 248).
Cluster analyses identified ASyS as a distinct and heterogeneous clinical entity. Three distinct phenotypic clusters emerged among patients with ASyS, with ILD-predominant cases representing the second largest subgroup, underscoring the need for classification criteria that adequately capture patients presenting with isolated ILD.

PMID:
43016155
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement